Jagsonpal Pharmaceuticals (BOM:507789) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:507789 Jagsonpal Pharmaceuticals Ltd BOM:507789
73 GF Score
Price ₹233.30
GF Value ₹205.36
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Jagsonpal Pharmaceuticals FFO?

FFO (Funds from operations) only applies to REITs.

BOM:507789
73GF Score
Jagsonpal Pharmaceuticals Ltd BOM:507789
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Jagsonpal Pharmaceuticals (BOM:507789) Overvalued in 2026?

Based on GuruFocus' analysis, Jagsonpal Pharmaceuticals stock appears to be overvalued. The current stock price of ₹233.30 is trading 13.6% above its estimated GF Value™ of ₹205.36. GuruFocus considers Jagsonpal Pharmaceuticals to be Modestly Overvalued.

Key valuation signals for BOM:507789:

  • FFO:
  • GF Value™: ₹205.36 vs. price of ₹233.30 (13.6% above fair value)
  • GF Score™: 73/100 with 3 warning signs

No single metric tells the full story. See the BOM:507789 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Jagsonpal Pharmaceuticals Business Description

Other Exchanges JAGSNPHARM:India
Address 3rd Floor, Phase - IV, Udyog Vihar, Plot No. 412-415, Nimai Tower, Gurugram, HR, IND, 122015
Jagsonpal Pharmaceuticals Ltd is a pharmaceutical company. It develops and manufactures active pharmaceutical ingredients and formulations like Capsule and Tablet. The company operates in the Gynaecology, Orthopaedics, Dermatology and Paediatric segments. Its brands comprise Lycored, Maintane, Doxypal DR, and others.
73GF Score

Get the complete analysis for BOM:507789

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹233.30
Price
₹205.36
GF Value